Medical Diagnostics & Research Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Medical Diagnostics & Research
Personalis Inc (PSNL) (Q1 2024) Earnings Call Transcript Highlights: Surpassing Revenue Expectations and Strategic Advances
Personalis Inc (PSNL) reports a robust Q1 with significant revenue growth and strategic developments in biopharma collaborations and product launches. May 09, 2024
GuruFocus Research Medical Diagnostics & Research
Exact Sciences Corp (EXAS) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges
Discover how Exact Sciences Corp (EXAS) achieved a 6% revenue increase and navigated market challenges in the first quarter of 2024. May 09, 2024
GuruFocus Research Medical Diagnostics & Research
Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Improved Margins
Biodesix Inc reports a 64% increase in revenue and significant improvements in gross margins and EBITDA, despite ongoing challenges. May 09, 2024
GuruFocus Research Medical Diagnostics & Research
Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and Financial Health
Exploring the robust financial positioning and strategic developments of Aclaris Therapeutics in the first quarter of 2024. May 08, 2024
GuruFocus Research Medical Diagnostics & Research
Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue Surge and Record Testing Volumes
Explore key insights from Veracyte's Q1 2024 earnings, including significant revenue growth, testing volume records, and strategic expansions. May 08, 2024
GuruFocus Research Medical Diagnostics & Research
Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Robust Revenue Growth and Strategic Realignments
Explore key insights from Myriad Genetics' Q1 2024 earnings, featuring significant revenue increases and strategic initiatives aimed at enhancing market position. May 08, 2024